Baxter Recalls Buretrol IV Products Over Air Leakage Risk

Law360, New York (November 9, 2012, 4:01 PM EST) -- Baxter Healthcare Corp. has initiated a voluntary recall of its Buretrol intravenous solution sets because of a potentially defective ball-valve feature that may allow air into a patient’s bloodstream, the U.S. Food and Drug Administration said Thursday.

“Baxter has determined that the ball-valve component is allowing air to flow past the valve and enter the tubing once the pre-measured amount of fluids is completely administered to the patient,” the FDA said in a statement.

If the air is not removed, the air present in the tubing...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.